Incidence, risk profile and morphological pattern of venous thromboembolism after prostate cancer surgery

被引:52
作者
Beyer, J. [1 ]
Wessela, S. [1 ]
Hakenberg, O. W. [2 ]
Kuhlisch, E. [3 ]
Halbritter, K. [1 ]
Froehner, M.
Wirth, M. P. [4 ]
Schellong, S. M. [1 ]
机构
[1] Tech Univ Dresden, Dept Med, Div Vasc Med, D-01307 Dresden, Germany
[2] Univ Rostock, Dept Urol, Rostock, Germany
[3] Tech Univ Dresden, Dept Biometr & Med Stat, Dresden, Germany
[4] Tech Univ Dresden, Dept Urol, Dresden, Germany
关键词
cancer surgery; deep vein thrombosis; prostate cancer; venous thromboembolism; VTE prophylaxis; RADICAL RETROPUBIC PROSTATECTOMY; MOLECULAR-WEIGHT HEPARIN; DEEP-VEIN THROMBOSIS; PELVIC LYMPHADENECTOMY; PULMONARY-EMBOLISM; JOINT REPLACEMENT; COMPLICATIONS; PROPHYLAXIS; THROMBOPROPHYLAXIS; LYMPHOCELES;
D O I
10.1111/j.1538-7836.2009.03275.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Venous thromboembolism (VTE) is the most common non-surgical complication after major pelvic surgery. Little is known about the risk factors or the time of development of postoperative venous thrombosis. Methods: A cohort of 523 consecutive patients undergoing radical prostatectomy with lymphadenectomy was prospectively assessed by complete compression ultrasound at days -1, +8 and +21. Results: Complete data were available in 415 patients, while four patients had VTE before surgery and were excluded from the analysis. In the remaining 411 patients, 71 VTE events were found in 69 patients (16.8%). Most were limited to calf muscle veins (56.5%), followed by deep calf vein thrombosis (23.2%), proximal deep vein thrombosis (DVT, 14.5%) and pulmonary embolism (PE, 5.8%). Of the 14 patients with proximal DVT/PE, 11 patients (78.6%) developed VTE between days 8 and 21. Risk factors for VTE were a personal history of VTE (OR 3.0), pelvic lymphoceles (LCs) impairing venous flow (OR 2.8) and necessity of more than two units of red blood cells (OR 2.6). Conclusion: Venous thromboembolism is common after radical prostatectomy. A significant proportion develops after day 8, suggesting that prolonged heparin prophylaxis should be considered. Since LCs with venous flow reduction result in higher rates of VTE, hemodynamically relevant lymphoceles should be surgically treated.
引用
收藏
页码:597 / 604
页数:8
相关论文
共 38 条
  • [21] Reduction of venous thromboembolism following prolonged prophylaxis with the low molecular weight heparin Certoparin after endoprothetic joint replacement or osteosynthesis of the lower limb in elderly patients
    Kolb, G
    Bodamer, I
    Galster, H
    Seidlmayer, C
    Grambach, K
    Koudela, K
    Eisele, RR
    Becker, C
    Paal, V
    Spannagel, U
    Brom, J
    Weidinger, G
    [J]. THROMBOSIS AND HAEMOSTASIS, 2003, 90 (06) : 1100 - 1105
  • [22] Prostate cancer in the elderly
    Konstantinos H.
    [J]. International Urology and Nephrology, 2005, 37 (4) : 797 - 806
  • [23] Venous thromboembolism in radical prostatectomy: is heparinoid prophylaxis warranted?
    Koya, MP
    Manoharan, M
    Kim, SS
    Soloway, MS
    [J]. BJU INTERNATIONAL, 2005, 96 (07) : 1019 - 1021
  • [24] COLOR DOPPLER FLOW IMAGING FOR DEEP VENOUS THROMBOSIS SCREENING IN PATIENTS UNDERGOING PELVIC LYMPHADENECTOMY AND RADICAL RETROPUBIC PROSTATECTOMY FOR PROSTATIC-CARCINOMA
    LEIBOVITCH, I
    FOSTER, RS
    WASS, JL
    ROWLAND, RG
    BIHRLE, R
    LITTLE, JS
    KOPECKY, KK
    DONOHUE, JP
    [J]. JOURNAL OF UROLOGY, 1995, 153 (06) : 1866 - 1869
  • [25] Intraoperative and postoperative complications of radical retropubic prostatectomy in a consecutive series of 1,000 cases
    Lepor, H
    Nieder, AM
    Ferrandino, MN
    [J]. JOURNAL OF UROLOGY, 2001, 166 (05) : 1729 - 1733
  • [26] American society of clinical oncology guideline: Recommendations for venous thromboembolism prophylaxis and treatment in patients with cancer
    Lyman, Gary H.
    Khorana, Alok A.
    Falanga, Anna
    Clarke-Pearson, Daniel
    Flowers, Christopher
    Jahanzeb, Mohammad
    Kakkar, Ajay
    Kuderer, Nicole M.
    Levine, Mark N.
    Liebman, Howard
    Mendelson, David
    Raskob, Gary
    Somerfield, Mark R.
    Liebman, Howard
    Mendelson, David
    Raskob, Gary
    Somerfield, Mark R.
    Thodiyil, Paul
    Trent, David
    Francis, Charles W.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (34) : 5490 - 5505
  • [27] Meta-analysis of low molecular weight heparin in the prevention of venous thromboembolism in general surgery
    Mismetti, P
    Laporte, S
    Darmon, JY
    Buchmüller, A
    Decousus, H
    [J]. BRITISH JOURNAL OF SURGERY, 2001, 88 (07) : 913 - 930
  • [28] Association between venous thromboembolism and perioperative allogeneic transfusion
    Nilsson, Kent R.
    Berenholtz, Sean M.
    Garrett-Mayer, Elizabeth
    Dorman, Todd
    Klag, Michael J.
    Pronovost, Peter J.
    [J]. ARCHIVES OF SURGERY, 2007, 142 (02) : 126 - 132
  • [29] Noldus J, 1997, J CANCER RES CLIN, V123, P180, DOI 10.1007/s004320050047
  • [30] ROSSIGNOL G, 1991, EUR UROL, V19, P186